Scientific Director, Physics
About the role
We are looking for an exceptional Scientific Director, Physics to lead our Physics organization and help shape the scientific foundation behind Novocure's next generation of product innovation.
In this highly visible leadership role, you will lead a team of physicists working at the intersection of physics, biology, engineering, and clinical science to advance our Tumor Treating Fields (TTFields) technology. As a member of the Product Development Leadership Team, you will provide scientific direction, develop organizational capabilities, and help solve complex multidisciplinary challenges that drive innovation from early discovery through clinical application.
This role requires both scientific depth and leadership excellence. You will build and develop a high-performing team, foster a hypothesis-driven approach to scientific problem solving, and influence strategic decisions across Product Development, Preclinical Research, Medical Affairs, Regulatory, and Clinical teams.
Success in this role means building a world-class physics organization, strengthening scientific capabilities, driving meaningful innovation, and translating complex scientific questions into practical solutions that accelerate product development and improve outcomes for patients.
This is a full-time position based at our R&D center in Haifa, Israel, reporting to the Global Head of Product Development.
What you will do
What you will bring
Who you are
ABOUT NOVOCURE
Novocure is a company with a powerful mission: to extend the lives of people living with some of the most aggressive forms of cancer.
Here, your work will have a direct impact on patients and those who care about them. Join a team of passionate, collaborative people who support each other, challenge one another, and innovate together.
Here, you’ll connect, grow, and make a real difference. We’re a company with the drive of a startup and the strength that comes with 25 years of success.
Novocure operates at a rare crossroads, where advanced medical technology converges with cutting-edge biotechnology.
We are the only company to develop and commercialize Tumor Treating Fields (TTFields), a proprietary, groundbreaking therapy designed to disrupt cancer cell division.
With us, you will find a unique combination of laboratory research work alongside engineering development of advanced technologies.
This fusion of disciplines positions us as true pioneers in oncology innovation, leading a new frontier in the treatment of aggressive cancers.
Our patient-forward values
– innovation
– focus
– drive
– courage
– trust
– empathy

We are a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of our innovative therapy, Tumor Treating Fields. Our commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma. We have ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer and gastric cancer.
Headquartered in Switzerland, Novocure has U.S. operations in Portsmouth, New Hampshire and Chesterbrook, Pennsylvania. Additionally, Novocure has offices in Canada, Germany, Japan, Poland and Israel.